Ji C, Xue GF, Lijun C, Feng P, Li D, Li L, Li G, Hlscher C
The authors claim that it is the most comprehensive collection of evidence on post-GLP-1RA weight outcomes to date. Weight regain after GLP-1 discontinuation The study searched multiple databases for randomized controlled trials (RCTs), non-randomized interventional studies, and observational studies examining weight trajectories after discontinuing GLP-1RAs
GLP-1 therapy works the same way for many patients, managing a metabolic condition rather than curing it
Comparison review of short-acting and long-acting glucagon-like peptide-1 receptor agonists
Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state
3.7 GLP-1RAs and obesity-associated cancers Obesity is a well-recognized risk factor for a range of malignancies